291 related articles for article (PubMed ID: 29138886)
1. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
Velázquez-Acosta C; Zarco-Márquez S; Jiménez-Andrade MC; Volkow-Fernández P; Cornejo-Juárez P
Support Care Cancer; 2018 Jun; 26(6):1953-1960. PubMed ID: 29307014
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
Imoto W; Yamada K; Yamairi K; Shibata W; Namikawa H; Yukawa S; Yoshii N; Nakaie K; Hirose A; Koh H; Watanabe T; Asai K; Nakamae H; Kaneko Y; Kawaguchi T; Hino M; Kakeya H
Intern Med; 2020; 59(2):193-198. PubMed ID: 31941869
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors and clinical charasteristics of Stenotrophomonas maltophilia bacteremia: a comparison with bacteremia due to other glucose-non fermenters].
Hotta G; Matsumura Y; Kato K; Nakano S; Yunoki T; Yamamoto M; Nagao M; Ito Y; Takakura S; Ichiyama S
Kansenshogaku Zasshi; 2013 Sep; 87(5):596-602. PubMed ID: 24195169
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis.
Kim SH; Cha MK; Kang CI; Ko JH; Huh K; Cho SY; Chung DR; Peck KR
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):285-295. PubMed ID: 30421302
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.
Ebara H; Hagiya H; Haruki Y; Kondo E; Otsuka F
Intern Med; 2017; 56(2):137-142. PubMed ID: 28090041
[TBL] [Abstract][Full Text] [Related]
9. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience.
Bao H; Qiao Y; Liu D; Chen J; Wu X; Hu X; Ma X; Wu D
Infection; 2020 Apr; 48(2):205-212. PubMed ID: 31686323
[TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
Cho SY; Lee DG; Choi SM; Park C; Chun HS; Park YJ; Choi JK; Lee HJ; Park SH; Choi JH; Yoo JH
BMC Infect Dis; 2015 Feb; 15():69. PubMed ID: 25887489
[TBL] [Abstract][Full Text] [Related]
12. Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study.
Zhu L; Wang L; Zhang Y; Chen R; Li X; Sun J; Zhou D; Zhu M; Zheng X; Li L; Zhu J; Xie M; Yang X; Yu W; Tong H; Zhu H; Xie W; Jin J; Ye X
BMC Infect Dis; 2021 Jul; 21(1):723. PubMed ID: 34332526
[TBL] [Abstract][Full Text] [Related]
13. Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.
Yilmaz M; Celik AF; Mert A
J Infect Chemother; 2007 Apr; 13(2):122-3. PubMed ID: 17458682
[TBL] [Abstract][Full Text] [Related]
14. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.
Araoka H; Fujii T; Izutsu K; Kimura M; Nishida A; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Transpl Infect Dis; 2012 Aug; 14(4):355-63. PubMed ID: 22283869
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
Tokatly Latzer I; Nahum E; Cavari Y; Lazar I; Ben-Ari Y; Ben-Shimol S; Ben-Shalom G; Geffen Y; Goldberg L; Rubinstein M; Keller N; Pessach IM; Paret G
Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792
[TBL] [Abstract][Full Text] [Related]
16. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
Aisenberg G; Rolston KV; Dickey BF; Kontoyiannis DP; Raad II; Safdar A
Eur J Clin Microbiol Infect Dis; 2007 Jan; 26(1):13-20. PubMed ID: 17200840
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Stenotrophomonas maltophilia bacteremia in children.
Furuichi M; Ito K; Miyairi I
Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084
[TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis.
Büyükcam A; Bıçakcıgil A; Cengiz AB; Sancak B; Ceyhan M; Kara A
Arch Argent Pediatr; 2020 Jun; 118(3):e317-e323. PubMed ID: 32470274
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for death from Stenotrophomonas maltophilia bacteremia.
Osawa K; Shigemura K; Kitagawa K; Tokimatsu I; Fujisawa M
J Infect Chemother; 2018 Aug; 24(8):632-636. PubMed ID: 29673561
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
